{"patient_id": 18475, "patient_uid": "7160902-2", "PMID": 32295619, "file_path": "comm/PMC007xxxxxx/PMC7160902.xml", "title": "Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter study", "patient": "Case 2 was a 74-year-old male with KIF5B-RET-rearranged stage IVA (cT1bN3M1b) lung adenocarcinoma. Baseline tissue showed a high level of PD-L1 expression (TPS > 50%). He was treated with first-line durvalumab and had confirmed partial response as the best response. Treatment is ongoing at the date of data cut-off.", "age": "[[74.0, 'year']]", "gender": "M", "relevant_articles": "{'31228184': 1, '30664810': 1, '25428505': 1, '19693097': 1, '28447912': 1, '26762747': 1, '23396013': 1, '33489826': 1, '28285689': 1, '29799009': 1, '27780855': 1, '28082048': 1, '30510250': 1, '30165392': 1, '27924752': 1, '31125062': 1, '29912274': 2, '24504365': 1, '22327623': 1, '30056164': 1, '26404496': 1, '29617662': 1, '28693542': 1, '27825636': 1, '34589933': 1, '29769722': 1, '30944026': 1, '23814043': 1, '30255938': 1, '27794403': 1, '27056998': 1, '19451168': 1, '31297240': 1, '31192313': 1, '29657135': 1, '30131091': 1, '30425105': 1, '31023335': 1, '30017832': 1, '22474122': 1, '27825616': 1, '28733428': 1, '34120433': 1, '26085931': 1, '27803005': 1, '32295619': 2}", "similar_patients": "{'7160902-1': 2, '6096733-1': 1, '6096733-2': 1}"}